首页> 外文期刊>Peptides: An International Journal >Differential gene expression of RAW 264.7 macrophages in response to the RGD peptide lunasin with and without lipopolysaccharide stimulation.
【24h】

Differential gene expression of RAW 264.7 macrophages in response to the RGD peptide lunasin with and without lipopolysaccharide stimulation.

机译:RAW 264.7巨噬细胞对RGD肽lunasin的反应(含和不含脂多糖刺激)的差异基因表达。

获取原文
获取原文并翻译 | 示例
       

摘要

Lunasin is a novel peptide from soybean with demonstrated chemopreventive property. We compared the effect of lunasin on gene expression of RAW 264.7 macrophages with and without lipopolysaccharide (LPS)-stimulation. Our hypothesis was that lunasin will have a differential effect in RAW 264.7 gene expression in a normal and challenged state. Analysis of the microarray data using False Discovery Rate (FDR) method resulted in the identification of 340 up-regulated and 162 down-regulated genes (FDR p-value <0.05) associated with simultaneous treatment of lunasin and LPS for 24h. Treatment of lunasin with no LPS for 24h resulted in the up-regulation of 855 genes and down-regulation of 397 genes. Pre-treatment of lunasin for 24h resulted in the up-regulation of 35 genes and down-regulation of 65 genes in LPS-stimulated RAW 264.7 macrophages. GeneVenn analysis of these three sets of genes showed that there are 66 genes common among the three groups which are mostly associated with regulation of cell death, ion binding and transcription as datamined by DAVID. Analysis of the 838 genes unique to lunasin alone by functional annotation clustering tool showed that lunasin mostly affected genes associated with RNA processing, apoptosis and protein kinase activity. Further datamining of these genes by ingenuity pathway analysis (IPA) showed that lunasin affected genes involved in cellular growth and proliferation, cellular function and maintenance, and cell to cell signaling and interaction. These findings support the potential chemopreventive and chemotherapeutic use of lunasin against cancer.
机译:Lunasin是来自大豆的新型肽,具有化学预防作用。我们比较了Lunasin对带有和不带有脂多糖(LPS)刺激的RAW 264.7巨噬细胞基因表达的影响。我们的假设是,在正常和挑战状态下,lunasin将对RAW 264.7基因表达产生差异作用。使用错误发现率(FDR)方法对微阵列数据进行分析后,鉴定出与Lunasin和LPS同时治疗24h相关的340个上调基因和162个下调基因(FDR p值<0.05)。在没有LPS的情况下处理lunasin 24小时,导致855个基因的上调和397个基因的下调。 Lunasin预处理24h导致LPS刺激的RAW 264.7巨噬细胞中35个基因的上调和65个基因的下调。 GeneVenn对这三组基因的分析表明,这三组基因之间共有66个共同的基因,这些基因主要与细胞凋亡的调控,离子结合和转录相关(如DAVID所收集的)。通过功能注释聚类工具分析了单独为lunasin独有的838个基因,结果表明lunasin主要影响与RNA加工,凋亡和蛋白激酶活性相关的基因。通过独创性途径分析(IPA)对这些基因进行的进一步数据挖掘表明,卢娜菌素影响的基因与细胞生长和增殖,细胞功能和维持以及细胞间信号传递和相互作用有关。这些发现支持了卢娜信可能用于化学预防和化学治疗癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号